Literature DB >> 19190258

Effects of chronic hypoglycemia and euglycemic correction on lysine metabolism in fetal sheep.

Sean W Limesand1, Paul J Rozance, Laura D Brown, William W Hay.   

Abstract

In this study, we determined rates of lysine metabolism in fetal sheep during chronic hypoglycemia and following euglycemic recovery and compared results with normal, age-matched euglycemic control fetuses to explain the adaptive response of protein metabolism to low glucose concentrations. Restriction of the maternal glucose supply to the fetus lowered the net rates of fetal (umbilical) glucose (42%) and lactate (36%) uptake, causing compensatory alterations in fetal lysine metabolism. The plasma lysine concentration was 1.9-fold greater in hypoglycemic compared with control fetuses, but the rate of fetal (umbilical) lysine uptake was not different. In the hypoglycemic fetuses, the lysine disposal rate also was higher than in control fetuses due to greater rates of lysine flux back into the placenta and into fetal tissue. The rate of CO2 excretion from lysine decarboxylation was 2.4-fold higher in hypoglycemic than control fetuses, indicating greater rates of lysine oxidative metabolism during chronic hypoglycemia. No differences were detected for rates of fetal protein accretion or synthesis between hypoglycemic and control groups, although there was a significant increase in the rate of protein breakdown (P<0.05) in the hypoglycemic fetuses, indicating small changes in each rate. This was supported by elevated muscle specific ubiquitin ligases and greater concentrations of 4E-BP1. Euglycemic recovery after chronic hypoglycemia normalized all fluxes and actually lowered the rate of lysine decarboxylation compared with control fetuses (P<0.05). These results indicate that chronic hypoglycemia increases net protein breakdown and lysine oxidative metabolism, both of which contribute to slower rates of fetal growth over time. Furthermore, euglycemic correction for 5 days returns lysine fluxes to normal and causes an overcorrection of lysine oxidation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19190258      PMCID: PMC2670627          DOI: 10.1152/ajpendo.90832.2008

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  28 in total

1.  Leucine disposal and oxidation rates in the fetal lamb.

Authors:  L C van Veen; C Teng; W W Hay; G Meschia; F C Battaglia
Journal:  Metabolism       Date:  1987-01       Impact factor: 8.694

2.  Fetal glucose metabolism and oxygen consumption during sustained hypoglycemia.

Authors:  J E DiGiacomo; W W Hay
Journal:  Metabolism       Date:  1990-02       Impact factor: 8.694

3.  Fetoplacental deamination and decarboxylation of leucine.

Authors:  G L Loy; A N Quick; W W Hay; G Meschia; F C Battaglia; P V Fennessey
Journal:  Am J Physiol       Date:  1990-10

4.  Identification of ubiquitin ligases required for skeletal muscle atrophy.

Authors:  S C Bodine; E Latres; S Baumhueter; V K Lai; L Nunez; B A Clarke; W T Poueymirou; F J Panaro; E Na; K Dharmarajan; Z Q Pan; D M Valenzuela; T M DeChiara; T N Stitt; G D Yancopoulos; D J Glass
Journal:  Science       Date:  2001-10-25       Impact factor: 47.728

5.  Fetal glucose uptake and utilization as functions of maternal glucose concentration.

Authors:  W W Hay; J W Sparks; R B Wilkening; F C Battaglia; G Meschia
Journal:  Am J Physiol       Date:  1984-03

6.  Partition of maternal glucose production between conceptus and maternal tissues in sheep.

Authors:  W W Hay; J W Sparks; R B Wilkening; F C Battaglia; G Meschia
Journal:  Am J Physiol       Date:  1983-10

7.  Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression.

Authors:  Stewart H Lecker; R Thomas Jagoe; Alexander Gilbert; Marcelo Gomes; Vickie Baracos; James Bailey; S Russ Price; William E Mitch; Alfred L Goldberg
Journal:  FASEB J       Date:  2004-01       Impact factor: 5.191

8.  Characterization of glucose transporter 8 (GLUT8) in the ovine placenta of normal and growth restricted fetuses.

Authors:  S W Limesand; T R H Regnault; W W Hay
Journal:  Placenta       Date:  2004-01       Impact factor: 3.481

9.  Insulin is required for amino acid stimulation of dual pathways for translational control in skeletal muscle in the late-gestation ovine fetus.

Authors:  Laura D Brown; Paul J Rozance; James S Barry; Jacob E Friedman; William W Hay
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-10-21       Impact factor: 4.310

10.  Rates of protein synthesis and turnover in fetal life.

Authors:  P R Meier; R G Peterson; D R Bonds; G Meschia; F C Battaglia
Journal:  Am J Physiol       Date:  1981-03
View more
  21 in total

Review 1.  Fetal adaptations in insulin secretion result from high catecholamines during placental insufficiency.

Authors:  Sean W Limesand; Paul J Rozance
Journal:  J Physiol       Date:  2017-05-26       Impact factor: 5.182

2.  Myoblasts from intrauterine growth-restricted sheep fetuses exhibit intrinsic deficiencies in proliferation that contribute to smaller semitendinosus myofibres.

Authors:  Dustin T Yates; Derek S Clarke; Antoni R Macko; Miranda J Anderson; Leslie A Shelton; Marie Nearing; Ronald E Allen; Robert P Rhoads; Sean W Limesand
Journal:  J Physiol       Date:  2014-05-23       Impact factor: 5.182

Review 3.  Postnatal Nutrient Repartitioning due to Adaptive Developmental Programming.

Authors:  Robert J Posont; Dustin T Yates
Journal:  Vet Clin North Am Food Anim Pract       Date:  2019-07       Impact factor: 3.357

4.  Skeletal muscle protein accretion rates and hindlimb growth are reduced in late gestation intrauterine growth-restricted fetal sheep.

Authors:  Paul J Rozance; Laura Zastoupil; Stephanie R Wesolowski; David A Goldstrohm; Brittany Strahan; Melanie Cree-Green; Melinda Sheffield-Moore; Giacomo Meschia; William W Hay; Randall B Wilkening; Laura D Brown
Journal:  J Physiol       Date:  2017-10-26       Impact factor: 5.182

5.  Skeletal muscle amino acid uptake is lower and alanine production is greater in late gestation intrauterine growth-restricted fetal sheep hindlimb.

Authors:  Eileen I Chang; Stephanie R Wesolowski; Elizabeth A Gilje; Peter R Baker; Julie A Reisz; Angelo D'Alessandro; William W Hay; Paul J Rozance; Laura D Brown
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-09-04       Impact factor: 3.619

6.  The obstetric and neonatal implications of a low value on the 50-g glucose screening test.

Authors:  Kimberly K Ma; Lisa Mele; Mark B Landon; Catherine Y Spong; Susan M Ramin; Brian Casey; Ronald J Wapner; Michael W Varner; Dwight J Rouse; John M Thorp; Anthony Sciscione; Patrick Catalano; Margaret Harper; George Saade; Steve N Caritis; Yoram Sorokin; Alan M Peaceman
Journal:  Am J Perinatol       Date:  2012-12-27       Impact factor: 1.862

Review 7.  The intrauterine growth restriction phenotype: fetal adaptations and potential implications for later life insulin resistance and diabetes.

Authors:  Stephanie R Thorn; Paul J Rozance; Laura D Brown; William W Hay
Journal:  Semin Reprod Med       Date:  2011-06-27       Impact factor: 1.303

Review 8.  Consequences of a compromised intrauterine environment on islet function.

Authors:  Alice S Green; Paul J Rozance; Sean W Limesand
Journal:  J Endocrinol       Date:  2010-03-11       Impact factor: 4.286

9.  Adrenal Demedullation and Oxygen Supplementation Independently Increase Glucose-Stimulated Insulin Concentrations in Fetal Sheep With Intrauterine Growth Restriction.

Authors:  Antoni R Macko; Dustin T Yates; Xiaochuan Chen; Leslie A Shelton; Amy C Kelly; Melissa A Davis; Leticia E Camacho; Miranda J Anderson; Sean W Limesand
Journal:  Endocrinology       Date:  2016-03-03       Impact factor: 4.736

10.  Lower oxygen consumption and Complex I activity in mitochondria isolated from skeletal muscle of fetal sheep with intrauterine growth restriction.

Authors:  Alexander L Pendleton; Andrew T Antolic; Amy C Kelly; Melissa A Davis; Leticia E Camacho; Kevin Doubleday; Miranda J Anderson; Paul R Langlais; Ronald M Lynch; Sean W Limesand
Journal:  Am J Physiol Endocrinol Metab       Date:  2020-05-12       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.